A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)

• Status: COMPLETED
• Trial end date: 2025-03-10

Summary

The study will be conducted to evaluate the clinical symptom improvement and safety of oral gepotidacin for treatment of uncomplicated UTI (acute cystitis) in adolescent and adult female participants.

• Phase: PHASE3

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: gepotidacin